✦ LIBER ✦

Adherence to Gastroprotective Agents and the Risk of Upper Gastrointestinal Complications in Coxib Users

✍ Scribed by Valkhoff, Vera E. ;van Soest, Eva M. ;Mazzaglia, Giampiero ;Schade, Rene ;Molokhia, Mariam ;Goldstein, Jay L. ;Hernandez-Diaz, Sonia ;Trifiro, Gianluca ;Dieleman, Jeanne ;Kuipers, Ernst J. ;Sturkenboom, Miriam C.

Book ID: 122118039
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 106 KB
Volume: 140
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(11)62420-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

AO4 ADHERENCE TO GASTROPROTECTION AND TH

AO4 ADHERENCE TO GASTROPROTECTION AND THE RISK OF NSAID-RELATED UPPER GASTROINTESTINAL COMPLICATIONS

✍ E Van Soest; MC Sturkenboom; JP Dieleman; K Verhamme; PD Siersema; E Kuipers 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Risk of Upper Gastrointestinal Complicat

Risk of Upper Gastrointestinal Complications Among Users of Traditional NSAIDs and COXIBs in the General Population

✍ Luis A. García Rodríguez; Laura Barreales Tolosa 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 208 KB

Underutilization of gastroprotective str

Underutilization of gastroprotective strategies in aspirin users at increased risk of upper gastrointestinal complications

✍ L. E. TARGOWNIK; C. J. METGE; S. LEUNG 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB

Adherence to gastroprotection and the ri

Adherence to gastroprotection and the risk of NSAID-related upper gastrointestinal ulcers and haemorrhage

✍ E. M. VAN SOEST; M. C. J. M. STURKENBOOM; J. P. DIELEMAN; K. M. C. VERHAMME; P. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 526 KB

Suboptimal Gastroprotective Coverage of

Suboptimal Gastroprotective Coverage of NSAID Use and the Risk of Upper Gastrointestinal Complications

✍ Eva M. van Soest; Vera E. Valkhoff; Giampiero Mazzaglia; Rene Schade; Mariam Mol 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Adherence to gastroprotection during cyc

Adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment and the risk of upper gastrointestinal tract events: A population-based study

✍ Vera E. Valkhoff; Eva M. van Soest; Giampiero Mazzaglia; Mariam Molokhia; René S 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB